A nationwide retrospective study to clarify the adequate treatment strategy for pancreatic cancer with positive peritoneal cytology
- Conditions
- pancreatic cancer
- Registration Number
- JPRN-UMIN000048808
- Lead Sponsor
- Tohoku University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 766
Not provided
(1) Patients who have not been diagnosed as pancreatic adenocarcinoma histologically or cytologically (2) Patients diagnosed with distant metastasis by various imaging tests (3) Patients with active multiple cancers (synchronous multiple cancers and heterochronic multiple cancers with a disease-free period of 5 years or less) at the time of CY1 diagnosis (4) Patients diagnosed with Papanicolaou classification Class III or lower by laparoscopic cytology. (5) Other cases that the investigator(s) deems inappropriate for this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.